Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Forrer

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumorsGiampiero Giovacchini, Guillaume Nicolas, Flavio Forrer
Psychiatrische Praxis|January 14, 2003
[Schizophrenia in the German national paper Frankfurter Allgemeine Zeitung -- a didactic play]Ulrike Hoffmann-Richter, Flavio Forrer, Asmus Finzen
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Targeted radiotherapy with radiolabeled somatostatin analogsGuillaume Nicolas, Giampiero Giovacchini, Jan Müller-Brand, et al.
Anticancer Research|June 3, 2006
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumorsFlavio Forrer, Christian Waldherr, Helmut R Maecke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2011
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapyGiampiero Giovacchini, Guillaume Nicolas, Heike Freidank, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2011
Radiopeptide imaging and therapy in EuropeValentina Ambrosini, Melpomeni Fani, Stefano Fanti, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Case report: Intraosseous hibernoma (IOH) mimics osseous metastasis: another rare pitfall in FDG-PET-CTSebastian J Stolte, Hanna Geiger, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolateCristina Müller, Flavio Forrer, Roger Schibli, et al.
Nuclear Medicine and Biology|August 21, 2007
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneysCristina Müller, Roger Schibli, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOCFlavio Forrer, Helena Uusijärvi, Daniel Storch, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumorsGiampiero Giovacchini, Guillaume Nicolas, Flavio Forrer
Psychiatrische Praxis|January 14, 2003
[Schizophrenia in the German national paper Frankfurter Allgemeine Zeitung -- a didactic play]Ulrike Hoffmann-Richter, Flavio Forrer, Asmus Finzen
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Targeted radiotherapy with radiolabeled somatostatin analogsGuillaume Nicolas, Giampiero Giovacchini, Jan Müller-Brand, et al.
Anticancer Research|June 3, 2006
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumorsFlavio Forrer, Christian Waldherr, Helmut R Maecke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2011
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapyGiampiero Giovacchini, Guillaume Nicolas, Heike Freidank, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2011
Radiopeptide imaging and therapy in EuropeValentina Ambrosini, Melpomeni Fani, Stefano Fanti, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Case report: Intraosseous hibernoma (IOH) mimics osseous metastasis: another rare pitfall in FDG-PET-CTSebastian J Stolte, Hanna Geiger, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolateCristina Müller, Flavio Forrer, Roger Schibli, et al.
Nuclear Medicine and Biology|August 21, 2007
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneysCristina Müller, Roger Schibli, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOCFlavio Forrer, Helena Uusijärvi, Daniel Storch, et al.
Pageof 4